Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Capitol Capsule: SCOTUS not ACA cure-all: drug access remains problematic

This article was originally published in Scrip

Executive Summary

Even though the US Supreme Court last week upheld the tax credit subsidies provision of the Affordable Care Act (ACA), ensuring eligible Americans who enrolled in plans operated by the federal government could keep the benefit, making it more likely they will be able to afford their coverage – and in so doing, ensuring biopharmaceutical makers and others in the healthcare sector retain their millions of new customers – there remains some barriers preventing access to care, including to needed medicines, two large drug trade groups pointed out.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC029092

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel